3K8-53952-94248
2 vaccinations
1 coded response
15 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 378 / TN
- Registered
- 2020-12-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-30
Registered in v-safe
-
2020-12-30
Dose 1 — Pfizer-BioNTech
- 2020-12-30
- 2020-12-31
- 2021-01-01
- 2021-01-03
- 2021-01-06
- 2021-01-13
- 2021-01-21
-
2021-01-22
Dose 2 — Pfizer-BioNTech
-
2021-01-25
Survey response — days 1–6 daily, dose 2MedDRA: Asthma, Hypersensitivity, Urticaria — Feeling: Good · Site: PainFree text: Mild allergic reaction day of my 2nd vaccine. Generalized hives and a mild asthma attack.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-26
- 2021-01-27
- 2021-02-12
- 2021-02-19
- 2021-02-26
- 2021-03-05
- 2021-04-23
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-30 | Pfizer-BioNTech | |
| 2 | 2021-01-22 | Pfizer-BioNTech |
Free text
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): Mild allergic reaction day of my 2nd vaccine. Generalized hives and a mild asthma attack.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Asthma | ✓ | ✓ | ✓ |
| SRO | Hypersensitivity | ✓ | ✓ | ✓ |
| SRO | Urticaria | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release